Esophageal Surgery, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan.
Comprehensive Cancer Control, Akita University Graduate School of Medicine, Akita, Japan.
Esophagus. 2021 Jul;18(3):700-703. doi: 10.1007/s10388-020-00800-2. Epub 2020 Nov 20.
Esophageal cancer recurrence in solitary mediastinal lymph node that may possibly been left behind in the first surgery differs from other recurrence patterns because it is still local disease and offers the possibility of complete cure through resection, but it is technically difficult. We resected recurrent mediastinal lymph nodes in six cases. A left transthoracic approach was used in three patients. Other approaches were left thoracoabdominal, right open transthoracic and transcervical. R0 resections were achieved in five patients without severe surgical stress or postoperative complications. Overall survival after resection of recurrent lymph nodes was 43 (16-82) months. Approaches to resection of recurrent solitary mediastinal lymph nodes after esophagectomy should be consider to perform curative treatment safely and less invasively.
食管癌术后孤立性纵隔淋巴结复发与其他复发模式不同,因为它仍然是局部疾病,通过切除仍有完全治愈的可能,但技术上具有难度。我们对 6 例复发的纵隔淋巴结进行了切除。3 例患者采用左经胸入路,其他入路包括左胸腹联合、右开胸经胸和经颈。5 例患者达到了 R0 切除,没有严重的手术应激或术后并发症。切除复发淋巴结后的总生存时间为 43(16-82)个月。对于食管癌术后孤立性纵隔淋巴结复发,应考虑采用安全、微创的方法进行根治性治疗。